Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.05, $0.02 better than the analyst estimate of $2.03. Revenue for the quarter came in at $20.3 billion versus the consensus estimate of $20.03 billion.

GUIDANCE:

Johnson & Johnson sees FY2018 EPS of $8.13-$8.18, versus the consensus of $8.15. Johnson & Johnson sees FY2018 revenue of $81-81.4 billion, versus the consensus of $81.21 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.